Search
Close this search box.

Diagnosis, Monitoring, and Management of Hepatitis C

Continuing Medical Education Information

Course Description:
This activity will address the diagnosis and treatment of the Hepatitis C Virus. Attendees will learn about Kentucky’s Hepatitis C Elimination Plan and strategies for communicating with patients and overcoming prior authorization barriers.

Statement of Need:
78,000 physicians are living with Hepatitis C Virus. These numbers may not be accurate as many people may not be screened and/or diagnosed for the virus.  Significant savings would be generated through increased investment in HCV outreach, screening, and treatment:

  • Private Insurance: $10-14 billion over 20 years
  • Medicare: $4-12 billion over 20 years5
  • Medicaid: $3.8 billion over enrollees’ lifetime

Citation:  https://aidsinstitute.net/documents/Fact-Sheet—Treating-Hepatitis-C-Saves-Lives-and-Money.pdf

Physicians need to be able to assess, diagnose, treat and refer patients who may be at risk for HPC Virus.  Lack of information about available treatments and proper screening and communication exist and can be addressed through education opportunities and availability of resources. 

Objectives:

OVERVIEW:

  • Describe the epidemiologic profile of the hepatitis C epidemic in the United States and in Kentucky.

HEPATITIS ELIMINATION PLAN

  • Provide overview of elimination plan and strategy

COUNSELING/PATIENT DISCUSSION:

  • Summarize common routes of HCV transmission
  • Discuss appropriate counseling to prevent transmission of HCV
  • Utilization of appropriate language when speaking to patients

SCREENING RECOMMENDATIONS/TESTING

  • Describe screening and supplemental tests used for diagnosing HCV infection

TREATMENT

  • Clinical features of patients presenting with acute HCV infection
  • Compare previous treatment vs. current treatment
    • Discuss easy pathways to treatment

BARRIERS

  • Medicaid barriers-prior authorization
  • Tips for successful prior authorization submission

FUTURE OF TREATMENT APPROACHES

  • Discussion of regulations and changes in the next 2-5 years

Disclosure:  All planners and speakers disclose that they have no relevant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Commercial Support: There is no commercial support associated with this activity.

Accreditation and Designation:
The Kentucky Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

The Kentucky Medical Association designates this enduring material activity for 1.oo AMA PRA Category 1 credit.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Resources
The KDPH VHP website has a list of resource links including:

Kentucky’s Hepatitis C Elimination Plan: HepatitisCEliminationPlan.pdf (ky.gov)

Elimination Plan Infographic: ElimPlanInfographic.pdf (ky.gov)

HCV disease burden modeling report for Kentucky: BurdenFinalReportCDAF.pdf (ky.gov)

Kentucky Hepatitis Academic Mentorship Program (KHAMP): Kentucky Rural Health Association – KHAMP (kyrha.org)

Kentucky’s Hep Elimination “Report Card”: Kentucky | Eliminate Hep

Fact Sheet on Cost-effectiveness of HCV Treatment: Fact Sheet MAY 2021 (aidsinstitute.net)

Estimated Time to Complete: This module will take approximately 1 hour to complete.

Method of Participation Used: Participants will view and listen to a recorded lecture while simultaneously viewing slides.

Hardware/Software Requirements: High speed internet connection

Meeting Planner: Miranda Mosley, Rachel Crouch

Provider Contact Information: Miranda Mosley, Kentucky Medical Association

Copyright: There is no copyright associated with this activity

Release Date: February 2023           

Termination Date:
February 2024

Click here to access the activity